You are here

China drugmaker in US$764m IPO

[HONG KONG] Luye Pharma Group, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and the company's owners are poised to raise US$764 million from a Hong Kong initial public offering, people with knowledge of the matter said.

The company, based in eastern China's Yantai city...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes